According to the latest report by IMARC Group, titled “Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the . An autoimmune disease is a condition wherein the immune system attacks and destroys healthy cells, tissues, and organs of the body. Eventually, it can lead to abnormal growth of an organ or improper organ function. Few common autoimmune disorders are Systemic Lupus Erythematosus (SLE), multiple sclerosis, rheumatoid arthritis, and type I diabetes. Based on the disease, different diagnostic procedures including physical examination, medical history, blood tests, biopsy, and X-rays, are adopted to provide an effective diagnosis. The healthcare professionals, via these diagnostic procedures, prescribe anti-inflammatory and immunosuppressant drugs, physical therapy, surgery, and injections, to monitor the overactive immune response and provide relief from the symptoms.
Request Free Sample Report: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/requestsample
The high prevalence of autoimmune diseases has led to the increasing adoption of advanced technologies for conducting multiple tests with faster and more accurate results. Additionally, several healthcare bodies are conducting numerous public awareness campaigns for autoimmune diseases and their available treatments, thereby further inducing the market growth. Moreover, various governing authorities and non-governing organizations are increasingly investing in the development of novel therapeutics, which are expected to bolster the autoimmune disease diagnosis market. Looking forward, IMARC Group expects the global autoimmune disease diagnosis market to continue its moderate growth during the next five years.
Breakup by Product Type:
- Consumables and Assay Kits
- Instruments
Breakup by Disease Type:
- Systemic Autoimmune Disease
- Rheumatoid Arthritis
- Psoriasis
- Systemic Lupus Erythematosus (SLE)
- Multiple Sclerosis
- Others
- Localized Autoimmune Disease
- Inflammatory Bowel Disease
- Type 1 Diabetes
- Thyroid
- Others
Breakup by Test Type:
- Routine Laboratory Tests
- Inflammatory Markers
- Autoantibodies and Immunologic Tests
- Others
Breakup by End-User:
- Clinical Laboratories
- Hospitals
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape Key Player:
- Abbott Laboratories
- Diagnostics GmbH & Co. KG
- Beckman Coulter Inc. (Danaher Corporation)
- bioMérieux SA (Institut Mérieux)
- Bio-Rad Laboratories Inc.
- Euroimmun AG (PerkinElmer Inc.)
- Hemagen Diagnostics Inc.
- Inova Diagnostics Inc. (Werfen Group S.A.)
- Myriad Genetics Inc.
- Quest Diagnostics Incorporated
- Siemens Healthineers AG (Siemens AG)
- SQI Diagnostics
- Thermo Fisher Scientific Inc.
- Trinity Biotech
Explore Full Report with TOC & List of Figure:
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Single User: https://www.imarcgroup.com/checkout?id=2250&method=1
Corporate User: https://www.imarcgroup.com/checkout?id=2250&method=3
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 |
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
